• 1
    Nelson LJ, Wells CD. Tuberculosis in children: considerations for children from developing countries. Semin Paediatr Infect Dis 2004; 15: 150154.
  • 2
    Marais BJ, Hesseling AC, Gie RP, Schaaf HS, Beyers N. The burden of childhood tuberculosis and the accuracy of routine surveillance data in high -burden setting. Int J Lung Dis 2006; 10: 259263.
  • 3
    Comstock GW, Livesay VT, Woolpert SF. The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol 1974; 99: 131138.
  • 4
    Gedde-Dahl T. Tuberculosis infection in the light of tuberculin matriculation. Am J Hyg 1952; 56: 139214.
  • 5
    Marais BJ, Gie RP, Schaaf HS, Hesseling AC, Obihara CC, Starke JJ, Enarson DA, Donald PR, Beyers N. The natural history of disease of childhood intra-thoracic tuberculosis: a critical review of the pre-chemotherapy literature. Int J Tuberc Lung Dis 2004; 8: 392402.
  • 6
    WHO/HTM/TB/2006.371. Guidance for national tuberculosis programmes on the management of tuberculosis in children. WHO 2006. Available at:
  • 7
    Donald PR, Maher D, Maritz JS, Qazi S. Ethambutol dosage for the treatment of children: literature review and recommendations. Int J Tuberc Lung Dis 2006; 10: 13181330.
  • 8
    Schünemann HJ, Hill SR, Kakad M, Vist GE, Bellamy R, Stockman L, Wisløff TF, Del Mar C, Hayden F, et al. Transparent Development of the WHO Rapid Advice Guidelines. PLoS Medicine 2007; 4: e119.
  • 9
    Donald P. The chemotherapy of tuberculous lymphadenopathy in children. Tuberculosis (accepted for publication).
  • 10
    Donald P. Cerebrospinal fluid concentrations of antituberculosis agents in adults and children. Tuberculosis (submitted for publication).
  • 11
    Donald P. The chemotherapy of tuberculous meningitis in children and adults. Tuberculosis (submitted for publication).
  • 12
    Stefania C, Di Mario S, Lewinsohn D, Detjen A, Baronciani D, Magrini N, Richeldi L. Assessing evidence for currently used dosages of anti-tuberculosis drugs in children: a systematic review. Am J Respiratory Critical Care Med (submitted for publication).
  • 13
    Lanier VS, Russel WF, Heaton A, Robinson A. Concentrations of active isoniazid in serum and cerebrospinal fluid of patients with tuberculosis treated with isoniazid Pediatrics 1958; 21: 910914.
  • 14
    Zhu M, Starke JR, Burman WJ, et al. Population pharmacokinetic modeling of pyrazinamide in children and adults with tuberculosis. Pharmacother 2002; 22: 686695.
  • 15
    Graham SM, Bell DJ, Nyirongo S, Hartkoorn R, Ward SA, Molyneux EM. Low levels of pyrazinamide and ethambutol in children with tuberculosis and impact of age, nutritional status and human immunodeficiency virus infection. Antimicrob Agents Chemother 2006; 50: 407413.
  • 16
    Ramachandran P, Kripasankar AS, Duraipandian M. Short course chemotherapy for pulmonary tuberculosis in children. Indian J Tuberc 1998; 45: 8387.
  • 17
    Menon P, Lodha R, Sivanandan S, Kabra S. Intermittent or daily short course chemotherapy for tuberculosis in children: meta-analysis of randomized controlled trials. Indian Pediatrics 2010; 47: 6773.
  • 18
    Kansoy S, Kurta N, Akit S, Aksoylar S, Yaprak I, Çalayan S. Superiority of intermittent-short course chemotherapy in childhood pulmonary tuberculosis. Turkish J Med Sci 1996; 26: 4143.
  • 19
    Gubkina MF, Ershova NG. Estimation of the possibilities of using unified chemotherapy regimens in new cases of pulmonary tuberculosis in old-age children and adolescents (Russian). Problemy Tuberkuleza I Boleznej Legkih 2009; 1: 3336.
  • 20
    Schulz, K. F, et al. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. J Am Medic Assoc 1995; 273(5): 408412.
  • 21
    Ritschel WA, Kearns GL. Handbook of basic pharmacokinetics including clinical applications, 6th edn. Washington, DC: American Pharmaceutical Association, 2004; 227240.
  • 22
    Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, Kauffman RE. Developmental Pharmacology—drug disposition, action, and therapy in infants and children. N Engl J Med 2003; 349: 11571167.
  • 23
    Bartelink IH, Rademaker CM, Schobben AF, van den Anker JN. Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations. Clin Pharmacokinet 2006; 45: 10771097.
  • 24
    Siber GR, Echeverria P, Smith AL, Paisley JW, Smith DH. Pharmacokinetics of gentamicin in children and adults. J Infect Dis 1975; 132: 637651.